HEADER BLOOD CLOTTING/IMMUNE SYSTEM 03-MAR-20 6M3B TITLE HAPC-C25K23 FAB COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ANTICOAGULANT PROTEIN C,AUTOPROTHROMBIN IIA,BLOOD COMPND 5 COAGULATION FACTOR XIV; COMPND 6 EC: 3.4.21.69; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: VITAMIN K-DEPENDENT PROTEIN C LIGHT CHAIN; COMPND 10 CHAIN: D; COMPND 11 SYNONYM: ANTICOAGULANT PROTEIN C,AUTOPROTHROMBIN IIA,BLOOD COMPND 12 COAGULATION FACTOR XIV; COMPND 13 EC: 3.4.21.69; COMPND 14 ENGINEERED: YES; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: C25K23 FAB L CHAIN; COMPND 17 CHAIN: B; COMPND 18 ENGINEERED: YES; COMPND 19 MOL_ID: 4; COMPND 20 MOLECULE: C25K23 FAB H CHAIN; COMPND 21 CHAIN: C; COMPND 22 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PROC; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: PROC; SOURCE 13 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_TAXID: 9606; SOURCE 18 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 19 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 20 MOL_ID: 4; SOURCE 21 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 22 ORGANISM_TAXID: 9606; SOURCE 23 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 24 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HUMAN APC, C25K23 FAB, COMPLEX, BLOOD CLOTTING, BLOOD CLOTTING-IMMUNE KEYWDS 2 SYSTEM COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR X.WANG,L.LI,X.ZHAO,U.EGNER REVDAT 3 29-NOV-23 6M3B 1 HETSYN REVDAT 2 29-JUL-20 6M3B 1 COMPND REMARK HETNAM LINK REVDAT 2 2 1 SITE REVDAT 1 08-JUL-20 6M3B 0 JRNL AUTH X.Y.ZHAO,A.WILMEN,D.WANG,X.WANG,M.BAUZON,J.Y.KIM,L.LINDEN, JRNL AUTH 2 L.LI,U.EGNER,T.MARQUARDT,D.MOOSMAYER,J.TEBBE,J.M.GLUCK, JRNL AUTH 3 P.ELLINGER,K.MCLEAN,S.YUAN,S.YEGNESWARAN,X.JIANG,V.EVANS, JRNL AUTH 4 J.M.GU,D.SCHNEIDER,Y.ZHU,Y.XU,C.MALLARI,A.HESSLEIN,Y.WANG, JRNL AUTH 5 N.SCHMIDT,K.GUTBERLET,C.RUEHL-FEHLERT,A.FREYBERGER, JRNL AUTH 6 T.HERMISTON,C.PATEL,D.SIM,L.O.MOSNIER,V.LAUX JRNL TITL TARGETED INHIBITION OF ACTIVATED PROTEIN C BY A JRNL TITL 2 NON-ACTIVE-SITE INHIBITORY ANTIBODY TO TREAT HEMOPHILIA. JRNL REF NAT COMMUN V. 11 2992 2020 JRNL REFN ESSN 2041-1723 JRNL PMID 32532974 JRNL DOI 10.1038/S41467-020-16720-9 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.15.2_3472 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.54 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 3 NUMBER OF REFLECTIONS : 57099 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.220 REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.110 REMARK 3 FREE R VALUE TEST SET COUNT : 2920 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 27.5420 - 6.0492 0.91 2495 132 0.2091 0.2362 REMARK 3 2 6.0492 - 4.8098 0.97 2619 134 0.1780 0.2010 REMARK 3 3 4.8098 - 4.2042 0.98 2599 150 0.1582 0.2065 REMARK 3 4 4.2042 - 3.8209 0.98 2580 150 0.1915 0.1821 REMARK 3 5 3.8209 - 3.5476 0.98 2604 140 0.2014 0.2157 REMARK 3 6 3.5476 - 3.3389 0.98 2610 123 0.2062 0.2436 REMARK 3 7 3.3389 - 3.1719 0.98 2620 132 0.2306 0.2333 REMARK 3 8 3.1719 - 3.0340 0.98 2591 149 0.2426 0.2864 REMARK 3 9 3.0340 - 2.9173 0.98 2561 163 0.2540 0.2804 REMARK 3 10 2.9173 - 2.8168 0.98 2588 150 0.2470 0.2640 REMARK 3 11 2.8168 - 2.7288 0.98 2569 127 0.2651 0.3006 REMARK 3 12 2.7288 - 2.6508 0.98 2592 145 0.2692 0.3706 REMARK 3 13 2.6508 - 2.5811 0.98 2641 110 0.2865 0.3283 REMARK 3 14 2.5811 - 2.5182 0.98 2583 120 0.2815 0.4044 REMARK 3 15 2.5182 - 2.4610 0.97 2544 129 0.2899 0.3452 REMARK 3 16 2.4610 - 2.4086 0.97 2616 131 0.2928 0.3266 REMARK 3 17 2.4086 - 2.3605 0.97 2524 148 0.3046 0.4050 REMARK 3 18 2.3605 - 2.3159 0.97 2547 156 0.3244 0.3546 REMARK 3 19 2.3159 - 2.2746 0.97 2569 144 0.3272 0.4008 REMARK 3 20 2.2746 - 2.2361 0.97 2549 141 0.3419 0.4113 REMARK 3 21 2.2361 - 2.2000 0.97 2578 146 0.3514 0.3840 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.310 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 33.840 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 65.44 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6M3B COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 12-MAR-20. REMARK 100 THE DEPOSITION ID IS D_1300015986. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-APR-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 57099 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.09600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 32.2200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.26 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.98900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.040 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1AUT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.19 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1% N-OCTYL-BETA-D-GLUCOSIDE, 0.1M REMARK 280 SODIUM CITRATE TRIBASIC DEHYDRATE PH 5.5, 22% (W/V) PEG 3350, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 56.13850 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.44450 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 56.13850 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 47.44450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 144A REMARK 465 SER A 144B REMARK 465 ARG A 144C REMARK 465 GLU A 144D REMARK 465 LYS A 144E REMARK 465 GLU A 144F REMARK 465 ALA A 144G REMARK 465 LYS A 144H REMARK 465 ARG A 144I REMARK 465 ASN A 144J REMARK 465 ARG A 144K REMARK 465 ASP A 244 REMARK 465 LYS A 245 REMARK 465 GLU A 246 REMARK 465 ALA A 247 REMARK 465 PRO A 248 REMARK 465 GLN A 249 REMARK 465 LYS A 250 REMARK 465 SER A 251 REMARK 465 TRP A 252 REMARK 465 ALA A 253 REMARK 465 PRO A 254 REMARK 465 ALA D 1 REMARK 465 ASN D 2 REMARK 465 SER D 3 REMARK 465 PHE D 4 REMARK 465 LEU D 5 REMARK 465 GLU D 6 REMARK 465 GLU D 7 REMARK 465 LEU D 8 REMARK 465 ARG D 9 REMARK 465 HIS D 10 REMARK 465 SER D 11 REMARK 465 SER D 12 REMARK 465 LEU D 13 REMARK 465 GLU D 14 REMARK 465 ARG D 15 REMARK 465 GLU D 16 REMARK 465 CYS D 17 REMARK 465 ILE D 18 REMARK 465 GLU D 19 REMARK 465 GLU D 20 REMARK 465 ILE D 21 REMARK 465 CYS D 22 REMARK 465 ASP D 23 REMARK 465 PHE D 24 REMARK 465 GLU D 25 REMARK 465 GLU D 26 REMARK 465 ALA D 27 REMARK 465 LYS D 28 REMARK 465 GLU D 29 REMARK 465 ILE D 30 REMARK 465 PHE D 31 REMARK 465 GLN D 32 REMARK 465 ASN D 33 REMARK 465 VAL D 34 REMARK 465 ASP D 35 REMARK 465 ASP D 36 REMARK 465 THR D 37 REMARK 465 LEU D 38 REMARK 465 ALA D 39 REMARK 465 PHE D 40 REMARK 465 TRP D 41 REMARK 465 SER D 42 REMARK 465 LYS D 43 REMARK 465 HIS D 44 REMARK 465 VAL D 45 REMARK 465 ASP D 46 REMARK 465 GLY D 47 REMARK 465 ASP D 48 REMARK 465 GLN D 49 REMARK 465 ASP D 71 REMARK 465 GLY D 72 REMARK 465 ILE D 73 REMARK 465 GLY D 74 REMARK 465 SER D 75 REMARK 465 LYS D 146 REMARK 465 ARG D 147 REMARK 465 MET D 148 REMARK 465 GLU D 149 REMARK 465 LYS D 150 REMARK 465 LYS D 151 REMARK 465 ARG D 152 REMARK 465 SER D 153 REMARK 465 HIS D 154 REMARK 465 LEU D 155 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 243 CG CD NE CZ NH1 NH2 REMARK 470 ARG D 87 CG CD NE CZ NH1 NH2 REMARK 470 TRP D 145 O CG CD1 CD2 NE1 CE2 CE3 REMARK 470 TRP D 145 CZ2 CZ3 CH2 REMARK 470 LEU C 98 O REMARK 470 ASP C 219 O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 70 N TYR A 71 1.69 REMARK 500 O HOH B 307 O HOH B 331 1.81 REMARK 500 O HOH A 402 O HOH A 423 1.89 REMARK 500 OG SER C 126 O HOH C 301 1.91 REMARK 500 O HOH B 332 O HOH B 335 2.01 REMARK 500 O HOH C 307 O HOH C 316 2.04 REMARK 500 O PRO D 122 O HOH D 301 2.08 REMARK 500 OG SER C 167 O HOH C 302 2.10 REMARK 500 O HOH A 406 O HOH A 428 2.14 REMARK 500 O ILE A 121 O HOH A 401 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG C 101 NE - CZ - NH2 ANGL. DEV. = 3.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 35 -166.57 -62.29 REMARK 500 CYS A 42 -171.58 -175.50 REMARK 500 HIS A 48 146.48 -179.41 REMARK 500 LYS A 63 35.95 -66.84 REMARK 500 TYR A 71 -52.79 -153.20 REMARK 500 THR A 99 38.03 39.67 REMARK 500 GLU A 129 -68.59 -125.59 REMARK 500 TYR A 143 103.37 -15.96 REMARK 500 SER A 214 -56.01 -123.67 REMARK 500 LEU D 51 -129.55 66.11 REMARK 500 VAL D 52 -144.94 -118.34 REMARK 500 SER D 77 130.09 166.26 REMARK 500 HIS D 107 -98.17 -114.85 REMARK 500 ASN B 28 -96.86 -131.63 REMARK 500 ASN B 53 -44.82 73.64 REMARK 500 ASN B 54 11.77 -148.03 REMARK 500 ALA B 86 -178.86 -173.09 REMARK 500 SER B 92 -146.33 -146.68 REMARK 500 ASN C 109 30.56 -156.73 REMARK 500 ASP C 112 120.43 -172.19 REMARK 500 SER C 143 -137.89 -91.99 REMARK 500 LEU C 200 -38.19 -162.19 REMARK 500 REMARK 500 REMARK: NULL DBREF 6M3B A 16 254 UNP P04070 PROC_HUMAN 212 461 DBREF 6M3B D 1 155 UNP P04070 PROC_HUMAN 43 197 DBREF 6M3B B 2 215 PDB 6M3B 6M3B 2 215 DBREF 6M3B C 1 223 PDB 6M3B 6M3B 1 223 SEQRES 1 A 250 LEU ILE ASP GLY LYS MET THR ARG ARG GLY ASP SER PRO SEQRES 2 A 250 TRP GLN VAL VAL LEU LEU ASP SER LYS LYS LYS LEU ALA SEQRES 3 A 250 CYS GLY ALA VAL LEU ILE HIS PRO SER TRP VAL LEU THR SEQRES 4 A 250 ALA ALA HIS CYS MET ASP GLU SER LYS LYS LEU LEU VAL SEQRES 5 A 250 ARG LEU GLY GLU TYR ASP LEU ARG ARG TRP GLU LYS TRP SEQRES 6 A 250 GLU LEU ASP LEU ASP ILE LYS GLU VAL PHE VAL HIS PRO SEQRES 7 A 250 ASN TYR SER LYS SER THR THR ASP ASN ASP ILE ALA LEU SEQRES 8 A 250 LEU HIS LEU ALA GLN PRO ALA THR LEU SER GLN THR ILE SEQRES 9 A 250 VAL PRO ILE CYS LEU PRO ASP SER GLY LEU ALA GLU ARG SEQRES 10 A 250 GLU LEU ASN GLN ALA GLY GLN GLU THR LEU VAL THR GLY SEQRES 11 A 250 TRP GLY TYR HIS SER SER ARG GLU LYS GLU ALA LYS ARG SEQRES 12 A 250 ASN ARG THR PHE VAL LEU ASN PHE ILE LYS ILE PRO VAL SEQRES 13 A 250 VAL PRO HIS ASN GLU CYS SER GLU VAL MET SER ASN MET SEQRES 14 A 250 VAL SER GLU ASN MET LEU CYS ALA GLY ILE LEU GLY ASP SEQRES 15 A 250 ARG GLN ASP ALA CYS GLU GLY ASP SER GLY GLY PRO MET SEQRES 16 A 250 VAL ALA SER PHE HIS GLY THR TRP PHE LEU VAL GLY LEU SEQRES 17 A 250 VAL SER TRP GLY GLU GLY CYS GLY LEU LEU HIS ASN TYR SEQRES 18 A 250 GLY VAL TYR THR LYS VAL SER ARG TYR LEU ASP TRP ILE SEQRES 19 A 250 HIS GLY HIS ILE ARG ASP LYS GLU ALA PRO GLN LYS SER SEQRES 20 A 250 TRP ALA PRO SEQRES 1 D 155 ALA ASN SER PHE LEU GLU GLU LEU ARG HIS SER SER LEU SEQRES 2 D 155 GLU ARG GLU CYS ILE GLU GLU ILE CYS ASP PHE GLU GLU SEQRES 3 D 155 ALA LYS GLU ILE PHE GLN ASN VAL ASP ASP THR LEU ALA SEQRES 4 D 155 PHE TRP SER LYS HIS VAL ASP GLY ASP GLN CYS LEU VAL SEQRES 5 D 155 LEU PRO LEU GLU HIS PRO CYS ALA SER LEU CYS CYS GLY SEQRES 6 D 155 HIS GLY THR CYS ILE ASP GLY ILE GLY SER PHE SER CYS SEQRES 7 D 155 ASP CYS ARG SER GLY TRP GLU GLY ARG PHE CYS GLN ARG SEQRES 8 D 155 GLU VAL SER PHE LEU ASN CYS SER LEU ASP ASN GLY GLY SEQRES 9 D 155 CYS THR HIS TYR CYS LEU GLU GLU VAL GLY TRP ARG ARG SEQRES 10 D 155 CYS SER CYS ALA PRO GLY TYR LYS LEU GLY ASP ASP LEU SEQRES 11 D 155 LEU GLN CYS HIS PRO ALA VAL LYS PHE PRO CYS GLY ARG SEQRES 12 D 155 PRO TRP LYS ARG MET GLU LYS LYS ARG SER HIS LEU SEQRES 1 B 214 SER VAL LEU THR GLN PRO PRO SER ALA SER GLY THR PRO SEQRES 2 B 214 GLY GLN ARG VAL THR ILE SER CYS THR GLY SER SER SER SEQRES 3 B 214 ASN ILE GLY ALA ALA TYR ASP VAL HIS TRP TYR GLN GLN SEQRES 4 B 214 LEU PRO GLY THR ALA PRO LYS LEU LEU ILE TYR GLY ASN SEQRES 5 B 214 ASN LYS ARG PRO SER GLY VAL PRO ASP ARG PHE SER GLY SEQRES 6 B 214 SER LYS SER GLY THR SER ALA SER LEU ALA ILE SER GLY SEQRES 7 B 214 LEU ARG SER GLU ASP GLU ALA ASP TYR TYR CYS GLN SER SEQRES 8 B 214 TYR ASP SER SER LEU SER GLY SER VAL PHE GLY GLY GLY SEQRES 9 B 214 THR LYS LEU THR VAL LEU GLY GLN PRO LYS ALA ALA PRO SEQRES 10 B 214 SER VAL THR LEU PHE PRO PRO SER SER GLU GLU LEU GLN SEQRES 11 B 214 ALA ASN LYS ALA THR LEU VAL CYS LEU ILE SER ASP PHE SEQRES 12 B 214 TYR PRO GLY ALA VAL THR VAL ALA TRP LYS ALA ASP SER SEQRES 13 B 214 SER PRO VAL LYS ALA GLY VAL GLU THR THR THR PRO SER SEQRES 14 B 214 LYS GLN SER ASN ASN LYS TYR ALA ALA SER SER TYR LEU SEQRES 15 B 214 SER LEU THR PRO GLU GLN TRP LYS SER HIS ARG SER TYR SEQRES 16 B 214 SER CYS GLN VAL THR HIS GLU GLY SER THR VAL GLU LYS SEQRES 17 B 214 THR VAL ALA PRO THR GLU SEQRES 1 C 223 GLU VAL GLN LEU LEU GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 C 223 PRO GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 C 223 PHE THR PHE SER SER TYR TRP MET SER TRP VAL ARG GLN SEQRES 4 C 223 ALA PRO GLY LYS GLY LEU GLU TRP VAL SER GLY VAL SER SEQRES 5 C 223 TRP ASN GLY SER ARG THR HIS TYR ALA ASP SER VAL LYS SEQRES 6 C 223 GLY ARG PHE THR ILE SER ARG ASP ASN SER LYS ASN THR SEQRES 7 C 223 LEU TYR LEU GLN MET ASN SER LEU ARG ALA GLU ASP THR SEQRES 8 C 223 ALA VAL TYR TYR CYS ALA LEU THR GLY ARG SER GLY TRP SEQRES 9 C 223 MET ARG PHE PRO ASN TRP PHE ASP PRO TRP GLY GLN GLY SEQRES 10 C 223 THR LEU VAL THR VAL THR SER ALA SER THR LYS GLY PRO SEQRES 11 C 223 SER VAL PHE PRO LEU ALA PRO SER SER LYS SER THR SER SEQRES 12 C 223 GLY GLY THR ALA ALA LEU GLY CYS LEU VAL LYS ASP TYR SEQRES 13 C 223 PHE PRO GLU PRO VAL THR VAL SER TRP ASN SER GLY ALA SEQRES 14 C 223 LEU THR SER GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SEQRES 15 C 223 SER SER GLY LEU TYR SER LEU SER SER VAL VAL THR VAL SEQRES 16 C 223 PRO SER SER SER LEU GLY THR GLN THR TYR ILE CYS ASN SEQRES 17 C 223 VAL ASN HIS LYS PRO SER ASN THR LYS VAL ASP LYS LYS SEQRES 18 C 223 VAL GLU HET NAG A 301 14 HET NAG D 201 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 5 NAG 2(C8 H15 N O6) FORMUL 7 HOH *139(H2 O) HELIX 1 AA1 ALA A 55 ASP A 60 5 6 HELIX 2 AA2 ASP A 125 GLU A 129 1 8 HELIX 3 AA3 PRO A 164 MET A 172 1 9 HELIX 4 AA4 TYR A 234 ARG A 243 1 10 HELIX 5 AA5 LEU D 100 CYS D 105 5 6 HELIX 6 AA6 ASN B 28 ALA B 32 5 5 HELIX 7 AA7 ARG B 81 GLU B 85 5 5 HELIX 8 AA8 SER B 126 ALA B 132 1 7 HELIX 9 AA9 THR B 186 SER B 192 1 7 HELIX 10 AB1 THR C 28 TYR C 32 5 5 HELIX 11 AB2 ASP C 62 LYS C 65 5 4 HELIX 12 AB3 ARG C 87 THR C 91 5 5 HELIX 13 AB4 SER C 167 ALA C 169 5 3 HELIX 14 AB5 LYS C 212 ASN C 215 5 4 SHEET 1 AA1 8 LYS A 20 MET A 21 0 SHEET 2 AA1 8 ASN A 156 VAL A 163 -1 O PHE A 157 N LYS A 20 SHEET 3 AA1 8 MET A 180 ALA A 183 -1 O CYS A 182 N VAL A 163 SHEET 4 AA1 8 GLY A 226 LYS A 230 -1 O TYR A 228 N LEU A 181 SHEET 5 AA1 8 THR A 206 TRP A 215 -1 N TRP A 215 O VAL A 227 SHEET 6 AA1 8 PRO A 198 PHE A 203 -1 N MET A 199 O VAL A 210 SHEET 7 AA1 8 GLU A 135 GLY A 140 -1 N LEU A 137 O VAL A 200 SHEET 8 AA1 8 ASN A 156 VAL A 163 -1 O ILE A 160 N THR A 136 SHEET 1 AA2 7 GLN A 30 LEU A 34 0 SHEET 2 AA2 7 LEU A 40 HIS A 48 -1 O ALA A 41 N LEU A 33 SHEET 3 AA2 7 TRP A 51 THR A 54 -1 O LEU A 53 N VAL A 45 SHEET 4 AA2 7 ALA A 104 LEU A 108 -1 O LEU A 106 N VAL A 52 SHEET 5 AA2 7 LEU A 81 VAL A 90 -1 N GLU A 87 O HIS A 107 SHEET 6 AA2 7 LEU A 65 LEU A 68 -1 N VAL A 66 O LEU A 83 SHEET 7 AA2 7 GLN A 30 LEU A 34 -1 N LEU A 34 O LEU A 65 SHEET 1 AA3 2 GLY D 67 CYS D 69 0 SHEET 2 AA3 2 CYS D 78 CYS D 80 -1 O ASP D 79 N THR D 68 SHEET 1 AA4 2 TRP D 84 GLU D 85 0 SHEET 2 AA4 2 ARG D 91 GLU D 92 -1 O ARG D 91 N GLU D 85 SHEET 1 AA5 2 TYR D 108 GLU D 111 0 SHEET 2 AA5 2 ARG D 116 SER D 119 -1 O ARG D 117 N LEU D 110 SHEET 1 AA6 2 TYR D 124 LEU D 126 0 SHEET 2 AA6 2 CYS D 133 PRO D 135 -1 O HIS D 134 N LYS D 125 SHEET 1 AA7 5 SER B 9 GLY B 12 0 SHEET 2 AA7 5 THR B 106 VAL B 110 1 O THR B 109 N ALA B 10 SHEET 3 AA7 5 ALA B 86 ASP B 94 -1 N ALA B 86 O LEU B 108 SHEET 4 AA7 5 HIS B 36 GLN B 40 -1 N GLN B 40 O ASP B 87 SHEET 5 AA7 5 LYS B 47 ILE B 50 -1 O ILE B 50 N TRP B 37 SHEET 1 AA8 4 SER B 9 GLY B 12 0 SHEET 2 AA8 4 THR B 106 VAL B 110 1 O THR B 109 N ALA B 10 SHEET 3 AA8 4 ALA B 86 ASP B 94 -1 N ALA B 86 O LEU B 108 SHEET 4 AA8 4 GLY B 99 PHE B 102 -1 O VAL B 101 N SER B 92 SHEET 1 AA9 3 VAL B 18 THR B 23 0 SHEET 2 AA9 3 SER B 72 ILE B 77 -1 O ALA B 73 N CYS B 22 SHEET 3 AA9 3 PHE B 64 SER B 69 -1 N SER B 65 O ALA B 76 SHEET 1 AB1 4 SER B 119 PHE B 123 0 SHEET 2 AB1 4 ALA B 135 PHE B 144 -1 O LEU B 140 N THR B 121 SHEET 3 AB1 4 TYR B 177 LEU B 185 -1 O LEU B 185 N ALA B 135 SHEET 4 AB1 4 VAL B 164 THR B 166 -1 N GLU B 165 O TYR B 182 SHEET 1 AB2 4 SER B 119 PHE B 123 0 SHEET 2 AB2 4 ALA B 135 PHE B 144 -1 O LEU B 140 N THR B 121 SHEET 3 AB2 4 TYR B 177 LEU B 185 -1 O LEU B 185 N ALA B 135 SHEET 4 AB2 4 SER B 170 LYS B 171 -1 N SER B 170 O ALA B 178 SHEET 1 AB3 4 SER B 158 PRO B 159 0 SHEET 2 AB3 4 THR B 150 ALA B 155 -1 N ALA B 155 O SER B 158 SHEET 3 AB3 4 TYR B 196 HIS B 202 -1 O THR B 201 N THR B 150 SHEET 4 AB3 4 SER B 205 VAL B 211 -1 O VAL B 207 N VAL B 200 SHEET 1 AB4 4 GLN C 3 SER C 7 0 SHEET 2 AB4 4 LEU C 18 SER C 25 -1 O SER C 25 N GLN C 3 SHEET 3 AB4 4 THR C 78 MET C 83 -1 O MET C 83 N LEU C 18 SHEET 4 AB4 4 PHE C 68 ASP C 73 -1 N SER C 71 O TYR C 80 SHEET 1 AB5 6 GLY C 10 VAL C 12 0 SHEET 2 AB5 6 THR C 118 VAL C 122 1 O THR C 121 N GLY C 10 SHEET 3 AB5 6 ALA C 92 ALA C 97 -1 N TYR C 94 O THR C 118 SHEET 4 AB5 6 MET C 34 GLN C 39 -1 N VAL C 37 O TYR C 95 SHEET 5 AB5 6 LEU C 45 VAL C 51 -1 O SER C 49 N TRP C 36 SHEET 6 AB5 6 THR C 58 TYR C 60 -1 O HIS C 59 N GLY C 50 SHEET 1 AB6 4 SER C 131 LEU C 135 0 SHEET 2 AB6 4 THR C 146 TYR C 156 -1 O LEU C 152 N PHE C 133 SHEET 3 AB6 4 TYR C 187 PRO C 196 -1 O TYR C 187 N TYR C 156 SHEET 4 AB6 4 VAL C 174 THR C 176 -1 N HIS C 175 O VAL C 192 SHEET 1 AB7 4 SER C 131 LEU C 135 0 SHEET 2 AB7 4 THR C 146 TYR C 156 -1 O LEU C 152 N PHE C 133 SHEET 3 AB7 4 TYR C 187 PRO C 196 -1 O TYR C 187 N TYR C 156 SHEET 4 AB7 4 VAL C 180 LEU C 181 -1 N VAL C 180 O SER C 188 SHEET 1 AB8 3 THR C 162 TRP C 165 0 SHEET 2 AB8 3 CYS C 207 HIS C 211 -1 O ASN C 208 N SER C 164 SHEET 3 AB8 3 THR C 216 VAL C 218 -1 O VAL C 218 N VAL C 209 SSBOND 1 CYS A 42 CYS A 58 1555 1555 2.05 SSBOND 2 CYS A 122 CYS D 141 1555 1555 2.05 SSBOND 3 CYS A 168 CYS A 182 1555 1555 2.03 SSBOND 4 CYS A 191 CYS A 219 1555 1555 2.02 SSBOND 5 CYS D 50 CYS D 69 1555 1555 2.03 SSBOND 6 CYS D 59 CYS D 64 1555 1555 2.04 SSBOND 7 CYS D 63 CYS D 78 1555 1555 2.05 SSBOND 8 CYS D 80 CYS D 89 1555 1555 2.07 SSBOND 9 CYS D 98 CYS D 109 1555 1555 1.99 SSBOND 10 CYS D 105 CYS D 118 1555 1555 2.12 SSBOND 11 CYS D 120 CYS D 133 1555 1555 2.05 SSBOND 12 CYS B 22 CYS B 90 1555 1555 2.05 SSBOND 13 CYS B 139 CYS B 198 1555 1555 2.03 SSBOND 14 CYS C 22 CYS C 96 1555 1555 2.05 SSBOND 15 CYS C 151 CYS C 207 1555 1555 2.04 LINK ND2 ASN A 93 C1 NAG A 301 1555 1555 1.44 LINK ND2 ASN D 97 C1 NAG D 201 1555 1555 1.44 CISPEP 1 TYR B 145 PRO B 146 0 -0.22 CISPEP 2 ASP C 112 PRO C 113 0 -4.54 CISPEP 3 PHE C 157 PRO C 158 0 -5.57 CISPEP 4 GLU C 159 PRO C 160 0 -1.64 CRYST1 112.277 94.889 114.320 90.00 105.49 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008907 0.000000 0.002468 0.00000 SCALE2 0.000000 0.010539 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009077 0.00000